For fiscal 2025 (ended Sep 30, 2025), Organigram Global Inc. reported C$259.18M of revenue and -C$24.76M of net income. Figures are in CAD, the currency of its SEC filings.
OGI revenue was C$259.18M for fiscal 2025 (ended Sep 30, 2025), up 62.2% from fiscal 2024. Compound annual growth was +24.5% over 5 years. Fiscal 2025 is the highest of the 7 fiscal years on file.
OGI net income was -C$24.76M for fiscal 2025 (ended Sep 30, 2025), compared with -C$45.44M in fiscal 2024.
OGI diluted EPS was -C$0.19 for fiscal 2025 (ended Sep 30, 2025), compared with -C$0.48 in fiscal 2024.
OGI free cash flow was -C$24.61M for fiscal 2025 (ended Sep 30, 2025), compared with -C$859.0K in fiscal 2024.
| Line item | Sep 30, 2025 | Sep 30, 2024 | Aug 31, 2022 | Aug 31, 2021 | Aug 31, 2020 | Aug 31, 2019 | Aug 31, 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | C$259.18M | C$159.84M | C$145.81M | C$79.16M | C$86.80M | C$80.41M | C$12.43M |
| Cost of revenue | C$174.85M | C$111.39M | C$119.04M | C$103.57M | C$105.00M | C$42.52M | C$5.53M |
| Gross profit | C$90.22M | C$47.52M | C$31.57M | -C$28.40M | -C$56.49M | C$48.47M | C$51.63M |
| Research and development | C$10.95M | C$11.20M | C$5.96M | C$3.65M | C$1.27M | C$409.0K | C$0 |
| Selling, general and admin | C$59.50M | C$44.95M | C$42.91M | C$29.92M | C$28.00M | C$18.59M | C$5.55M |
| Operating income | -C$15.30M | -C$34.76M | -C$43.15M | -C$91.82M | -C$145.51M | C$5.49M | C$36.42M |
| Interest expense | - | - | C$429.0K | C$2.96M | C$6.01M | C$9.67M | C$10.09M |
| Pre-tax income | -C$38.53M | -C$45.44M | -C$14.37M | -C$130.70M | -C$146.63M | -C$5.88M | C$27.78M |
| Income tax | -C$13.77M | C$0 | -C$88.0K | C$0 | -C$10.47M | C$3.63M | C$5.65M |
| Net income | -C$24.76M | -C$45.44M | -C$14.28M | -C$130.70M | -C$136.16M | -C$9.54M | C$20.51M |
| EPS, basic | -C$0.19 | -C$0.48 | -C$0.18 | -C$0.51 | -C$0.79 | -C$0.07 | C$0.17 |
| EPS, diluted | -C$0.19 | -C$0.48 | -C$0.18 | -C$0.51 | -C$0.79 | -C$0.07 | C$0.16 |
| Diluted shares | 127.7M | 95.3M | 77.2M | 256.1M | 178.1M | 151.5M | 126.9M |
| Line item | Sep 30, 2025 | Sep 30, 2024 | Aug 31, 2022 | Aug 31, 2021 | Aug 31, 2020 | Aug 31, 2019 | Aug 31, 2018 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | C$83.59M | C$132.60M | C$68.52M | C$55.37M | C$24.60M | C$47.55M | C$55.06M |
| Receivables | C$64.86M | C$37.15M | - | - | - | - | - |
| Inventory | C$106.02M | C$67.35M | C$50.31M | C$36.70M | C$66.36M | C$93.14M | C$44.97M |
| Current assets | C$284.90M | C$262.22M | C$221.62M | C$260.62M | C$170.20M | C$196.28M | C$203.21M |
| Goodwill | C$52.52M | C$0 | - | - | - | - | - |
| Total assets | C$562.21M | C$407.86M | C$577.11M | C$554.02M | C$435.13M | C$428.52M | C$302.57M |
| Current liabilities | C$126.16M | C$53.32M | C$55.28M | C$26.27M | C$29.08M | C$43.86M | C$11.25M |
| Long-term debt | C$0 | C$25.0K | C$155.0K | C$230.0K | C$103.67M | C$46.07M | C$2.88M |
| Total debt | C$0 | C$25.0K | C$155.0K | C$230.0K | C$103.67M | C$46.07M | C$2.88M |
| Total liabilities | C$213.08M | C$101.87M | C$69.05M | C$74.21M | C$135.60M | C$101.52M | C$117.97M |
| Shareholders' equity | C$349.13M | C$305.99M | C$508.06M | C$479.81M | C$299.53M | C$327.01M | C$184.59M |
| Line item | Sep 30, 2025 | Sep 30, 2024 | Aug 31, 2022 | Aug 31, 2021 | Aug 31, 2020 | Aug 31, 2019 | Aug 31, 2018 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -C$7.59M | C$3.87M | -C$36.21M | -C$28.59M | -C$45.13M | -C$35.08M | -C$12.70M |
| Capital expenditures | C$17.02M | C$4.73M | C$48.75M | C$11.76M | C$77.22M | C$108.76M | C$56.44M |
| Free cash flow | -C$24.61M | -C$859.0K | -C$84.96M | -C$40.35M | -C$122.35M | -C$143.84M | -C$69.14M |
| Investing cash flow | -C$81.07M | -C$30.80M | C$44.03M | -C$115.11M | -C$138.20M | -C$46.78M | -C$98.00M |
| Financing cash flow | C$39.33M | C$107.78M | C$5.33M | C$174.46M | C$160.37M | C$74.33M | C$163.91M |
| Stock-based compensation | C$4.22M | C$7.18M | C$5.13M | C$3.90M | C$7.80M | C$14.89M | C$5.03M |
| Depreciation and amortization | C$17.98M | C$12.08M | C$24.91M | C$31.03M | C$17.96M | C$8.90M | C$3.53M |
| Line item | Sep 30, 2025 | Sep 30, 2024 | Aug 31, 2022 | Aug 31, 2021 | Aug 31, 2020 | Aug 31, 2019 | Aug 31, 2018 |
|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 62.2% | - | 84.2% | -8.8% | 7.9% | 547.0% | - |
| Gross margin | 34.8% | 29.7% | 21.7% | -35.9% | -65.1% | 60.3% | 415.4% |
| Operating margin | -5.9% | -21.7% | -29.6% | -116.0% | -167.6% | 6.8% | 293.0% |
| Net margin | -9.6% | -28.4% | -9.8% | -165.1% | -156.9% | -11.9% | 165.0% |
| Free cash flow margin | -9.5% | -0.5% | -58.3% | -51.0% | -141.0% | -178.9% | -556.3% |
| Return on equity | -7.1% | -14.9% | -2.8% | -27.2% | -45.5% | -2.9% | 11.1% |
| Return on assets | -4.4% | -11.1% | -2.5% | -23.6% | -31.3% | -2.2% | 6.8% |
| Current ratio | 2.26 | 4.92 | 4.01 | 9.92 | 5.85 | 4.47 | 18.06 |
| Debt to equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.35 | 0.14 | 0.02 |
Source: XBRL data Organigram Global Inc. files with the SEC, latest filing dated Dec 16, 2025 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| OGI | C$259.18M | +62.2% | -C$24.76M | -9.6% | $123.6M |
| LLY | $86.46B | +45.5% | $27.58B | 31.9% | $1.33T |
| JNJ | $99.33B | +7.8% | $16.09B | 16.2% | $679.13B |
| ABBV | $66.01B | +10.7% | $10.34B | 15.7% | $518.44B |
| MRK | $67.38B | +4.9% | $2.45B | 3.6% | $366.73B |
| NVS | $54.53B | +8.4% | $13.98B | 25.6% | $312.35B |
| AZN | $58.74B | +8.6% | $10.22B | 17.4% | $293.69B |
| ABT | $48.23B | +10.0% | $4.70B | 9.7% | $191.40B |
| NVO | DKK 309.06B | +6.4% | DKK 102.43B | 33.1% | $183.23B |